Madrigal Pharmaceuticals, Inc. (MDGL)

546.19 -8.38 (-1.51%) USD  |  NASDAQ  |  Dec 17, 16:00
543.01 -3.18 (-0.58%) After-Hours: 20:00
More

Madrigal Pharmaceuticals Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade